News Digest / Ticker: PRME

Ticker: PRME

09:07am, Thursday, May 08, 2025

Prime Medicine Reports Q1 2025 Losses Amid Rising R&D Costs and Cash Reserves Concerns

Company Overview: Prime Medicine, Inc. (NASDAQ: PRME) is a biotechnology company focused on developing a new class of differentiated one-time curative genetic therapies. As of March 31, 2025, the company reported ongoing efforts in its research and development pipeline, particularly in genetic ed...

05:12am, Friday, Nov 15, 2024

Alibaba and Other Key Players Set to Report on November 15, 2024

S N P H

12:13pm, Saturday, May 25, 2024

Alphabet's Strategic Stock Picks: GitLab & Prime Medicine — High Stakes, High Rewards!